Correlation Between Mineralys Therapeutics, and Theriva Biologics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Theriva Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Theriva Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Theriva Biologics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Theriva Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Theriva Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Theriva Biologics.
Diversification Opportunities for Mineralys Therapeutics, and Theriva Biologics
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Mineralys and Theriva is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Theriva Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theriva Biologics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Theriva Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theriva Biologics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Theriva Biologics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Theriva Biologics
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Theriva Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Mineralys Therapeutics, Common is 1.87 times less risky than Theriva Biologics. The stock trades about -0.02 of its potential returns per unit of risk. The Theriva Biologics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 152.00 in Theriva Biologics on August 29, 2024 and sell it today you would lose (18.00) from holding Theriva Biologics or give up 11.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Theriva Biologics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Theriva Biologics |
Mineralys Therapeutics, and Theriva Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Theriva Biologics
The main advantage of trading using opposite Mineralys Therapeutics, and Theriva Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Theriva Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theriva Biologics will offset losses from the drop in Theriva Biologics' long position.| Mineralys Therapeutics, vs. Ultra Clean Holdings | Mineralys Therapeutics, vs. Playtika Holding Corp | Mineralys Therapeutics, vs. Helmerich and Payne | Mineralys Therapeutics, vs. Capital Clean Energy |
| Theriva Biologics vs. Lumos Pharma | Theriva Biologics vs. Avalo Therapeutics | Theriva Biologics vs. Virpax Pharmaceuticals | Theriva Biologics vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |